Cargando…

Metformin inhibits stromal aromatase expression and tumor progression in a rodent model of postmenopausal breast cancer

BACKGROUND: Obesity and type II diabetes are linked to increased breast cancer risk in postmenopausal women. Patients treated with the antidiabetic drug metformin for diabetes or metabolic syndrome have reduced breast cancer risk, a greater pathologic complete response to neoadjuvant therapy, and im...

Descripción completa

Detalles Bibliográficos
Autores principales:	Giles, Erin D., Jindal, Sonali, Wellberg, Elizabeth A., Schedin, Troy, Anderson, Steven M., Thor, Ann D., Edwards, Dean P., MacLean, Paul S., Schedin, Pepper
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2018
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6000949/ https://www.ncbi.nlm.nih.gov/pubmed/29898754 http://dx.doi.org/10.1186/s13058-018-0974-2

Ejemplares similares

Preventing ovariectomy-induced weight gain decreases tumor burden in rodent models of obesity and postmenopausal breast cancer
por: Wellberg, Elizabeth A., et al.
Publicado: (2022)

Characterization of weaning-induced breast involution in women: implications for young women’s breast cancer
por: Jindal, Sonali, et al.
Publicado: (2020)

Breaking down barriers: the importance of the stromal microenvironment in acquiring invasiveness in young women's breast cancer
por: Schedin, Pepper, et al.
Publicado: (2009)

Association Between Postpartum Breast Cancer Diagnosis and Metastasis and the Clinical Features Underlying Risk
por: Goddard, Erica T., et al.
Publicado: (2019)

Postpartum breast involution reveals regression of secretory lobules mediated by tissue-remodeling
por: Jindal, Sonali, et al.
Publicado: (2014)

Multistep tumorigenesis and the microenvironment
por: Schedin, Pepper, et al.
Publicado: (2004)

Developmental windows of breast cancer risk provide opportunities for targeted chemoprevention
por: Martinson, Holly A., et al.
Publicado: (2013)

Editorial: The Mammary Stroma in Normal Development and Function
por: Schedin, Pepper, et al.
Publicado: (2010)

Macrophages in Breast Cancer: Do Involution Macrophages Account for the Poor Prognosis of Pregnancy-Associated Breast Cancer?
por: O’Brien, Jenean, et al.
Publicado: (2009)

A Portal Vein Injection Model to Study Liver Metastasis of Breast Cancer
por: Goddard, Erica T., et al.
Publicado: (2016)

Loss of myoepithelial calponin‐1 characterizes high‐risk ductal carcinoma in situ cases, which are further stratified by T cell composition
por: Mitchell, Elizabeth, et al.
Publicado: (2020)

Young-Onset Breast Cancer Outcomes by Time Since Recent Childbirth in Utah
por: Zhang, Zhenzhen, et al.
Publicado: (2022)

Postpartum diagnosis demonstrates a high risk for metastasis and merits an expanded definition of pregnancy-associated breast cancer
por: Callihan, Eryn B., et al.
Publicado: (2013)

Ibuprofen supports macrophage differentiation, T cell recruitment, and tumor suppression in a model of postpartum breast cancer
por: Pennock, Nathan D., et al.
Publicado: (2018)

Vitamin D as a Potential Preventive Agent For Young Women's Breast Cancer
por: Bernhardt, Sarah M., et al.
Publicado: (2021)

Immune Milieu Established by Postpartum Liver Involution Promotes Breast Cancer Liver Metastasis
por: Bartlett, Alexandra Q., et al.
Publicado: (2021)

Extracellular vesicles from young women’s breast cancer patients drive increased invasion of non-malignant cells via the Focal Adhesion Kinase pathway: a proteomic approach
por: Jordan, Kimberly R., et al.
Publicado: (2020)

Pregnancy and Breast Cancer: when They Collide
por: Lyons, Traci R., et al.
Publicado: (2009)

Mammary Gland Involution Provides a Unique Model to Study the TGF-β Cancer Paradox
por: Guo, Qiuchen, et al.
Publicado: (2017)

S-nitrosylated and non-nitrosylated COX2 have differential expression and distinct subcellular localization in normal and breast cancer tissue
por: Jindal, Sonali, et al.
Publicado: (2020)

Overcoming Therapeutic Resistance of Triple Positive Breast Cancer with CDK4/6 Inhibition
por: Schedin, Troy B., et al.
Publicado: (2018)

RNA-seq from archival FFPE breast cancer samples: molecular pathway fidelity and novel discovery
por: Pennock, Nathan D., et al.
Publicado: (2019)

Postpartum breast cancer has a distinct molecular profile that predicts poor outcomes
por: Jindal, Sonali, et al.
Publicado: (2021)

Identifying significant temporal variation in time course microarray data without replicates
por: Billups, Stephen C, et al.
Publicado: (2009)

Body Mass Index Is Inversely Associated with Risk of Postmenopausal Interval Breast Cancer: Results from the Women’s Health Initiative
por: Zhang, Zhenzhen, et al.
Publicado: (2022)

Benign mammary epithelial cells enhance the transformed phenotype of human breast cancer cells
por: Poczobutt, Joanna M, et al.
Publicado: (2010)

Postpartum breast cancer: mechanisms underlying its worse prognosis, treatment implications, and fertility preservation
por: Lefrère, Hanne, et al.
Publicado: (2021)

COX-2 modulates mammary tumor progression in response to collagen density
por: Esbona, Karla, et al.
Publicado: (2016)

Comparison of Mortality Among Participants of Women’s Health Initiative Trials With Screening-Detected Breast Cancers vs Interval Breast Cancers
por: Irvin, Veronica L., et al.
Publicado: (2020)

Mammary extracellular matrix directs differentiation of testicular and embryonic stem cells to form functional mammary glands in vivo
por: Bruno, Robert D., et al.
Publicado: (2017)

Pharmacogenomics of aromatase inhibitors in postmenopausal breast cancer and additional mechanisms of anastrozole action
por: Cairns, Junmei, et al.
Publicado: (2020)

Simultaneous Quantification of Aromatase Inhibitors and Estrogens in Postmenopausal Breast Cancer Patients
por: Bertelsen, Bjørn-Erik, et al.
Publicado: (2021)

Associations of aspirin and other anti-inflammatory medications with breast cancer risk by the status of COX-2 expression
por: Yaghjyan, Lusine, et al.
Publicado: (2022)

A randomized phase II study of aromatase inhibitors plus metformin in pre-treated postmenopausal patients with hormone receptor positive metastatic breast cancer
por: Zhao, Yannan, et al.
Publicado: (2017)

Modeling Diet-Induced Obesity with Obesity-Prone Rats: Implications for Studies in Females
por: Giles, Erin D., et al.
Publicado: (2016)

Erythrocyte membrane fatty acids and breast cancer risk by tumor tissue expression of immuno-inflammatory markers and fatty acid synthase: a nested case-control study
por: McGee, Emma E., et al.
Publicado: (2020)

Adjuvant endocrine therapy for postmenopausal breast cancer in the era of aromatase inhibitors: an update
por: Mokbel, Ramia, et al.
Publicado: (2006)

Clinical Utility of Aromatase Inhibitors as Adjuvant Treatment in Postmenopausal Early Breast Cancer
por: Loaiza-Bonilla, Arturo, et al.
Publicado: (2013)

Incidence of menopausal symptoms in postmenopausal breast cancer patients treated with aromatase inhibitors
por: Hong, Dongsheng, et al.
Publicado: (2017)

Association of adjuvant aromatase inhibitor with cataract risk in postmenopausal women with breast cancer
por: Chen, Han, et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_nuuidekuocg9qmsic7e22gpr63